These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Acute phase proteins in systemic sclerosis. Whicher JT; Martin MF; Dieppe PA Lancet; 1981 Feb; 1(8215):329. PubMed ID: 6109967 [No Abstract] [Full Text] [Related]
3. Absence of prostaglandin stimulated increase in acute phase proteins in systemic sclerosis. Whicher JT; Martin MF; Dieppe PA Lancet; 1980 Nov; 2(8205):1187-8. PubMed ID: 6107783 [No Abstract] [Full Text] [Related]
4. Labour-associated increase in C-reactive protein concentration is not predictive of postpartum relapse activity among mothers with multiple sclerosis. Jalkanen A; Kauko T; Koskinen JO; Waris ME; Airas L Mult Scler; 2014 Nov; 20(13):1790-1. PubMed ID: 24696054 [No Abstract] [Full Text] [Related]
5. High sensitivity measurement of CRP and disease progression in multiple sclerosis. Soilu-Hänninen M; Koskinen JO; Laaksonen M; Hänninen A; Lilius EM; Waris M Neurology; 2005 Jul; 65(1):153-5. PubMed ID: 16009907 [TBL] [Abstract][Full Text] [Related]
6. Vitamin A and systemic inflammation as protective factors in multiple sclerosis. Salzer J; Hallmans G; Nyström M; Stenlund H; Wadell G; Sundström P Mult Scler; 2013 Jul; 19(8):1046-51. PubMed ID: 23334316 [TBL] [Abstract][Full Text] [Related]
7. [The significance of C-reactive protein determination in the diagnosis and evaluation of the clinical course of multiple sclerosis]. Hrazdira CL; Zouhar A; Polcáková M Cesk Neurol Neurochir; 1980 Sep; 43(5):290-5. PubMed ID: 7418055 [No Abstract] [Full Text] [Related]
8. [Biochemical data in multiple sclerosis]. Khondkarian OA; Larskiĭ EG; Bauman LK; Galuzo NV Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(12):1769-76. PubMed ID: 6000476 [No Abstract] [Full Text] [Related]
9. [Increased plasma C-reactive protein in a pregnant woman with multiple sclerosis: corticotherapy or not ?]. Limelette A; Caucheteux N; Ramont L; Tourbah A; Maquart FX Ann Biol Clin (Paris); 2010; 68(2):243-7. PubMed ID: 20348053 [TBL] [Abstract][Full Text] [Related]
10. Is there an association between the Expanded Disability Status Scale and inflammatory markers in multiple sclerosis? Guzel I; Mungan S; Oztekin ZN; Ak F J Chin Med Assoc; 2016 Feb; 79(2):54-7. PubMed ID: 26589195 [TBL] [Abstract][Full Text] [Related]
11. Association of serum gamma-glutamyltransferase and C-reactive proteins with neuromyelitis optica and multiple sclerosis. Shu Y; Li R; Qiu W; Chang Y; Sun X; Fang L; Chen C; Yang Y; Lu Z; Hu X; Kermode AG Mult Scler Relat Disord; 2017 Nov; 18():65-70. PubMed ID: 29107207 [TBL] [Abstract][Full Text] [Related]
12. [Experiences with cytostatic agents in multiple sclerosis]. Danielczyk W Wien Klin Wochenschr; 1970 Oct; 82(40):697-9. PubMed ID: 5522091 [No Abstract] [Full Text] [Related]
13. Cannabinoid influence on cytokine profile in multiple sclerosis. Katona S; Kaminski E; Sanders H; Zajicek J Clin Exp Immunol; 2005 Jun; 140(3):580-5. PubMed ID: 15932522 [TBL] [Abstract][Full Text] [Related]
14. MRM assay for quantitation of complement components in human blood plasma - a feasibility study on multiple sclerosis. Rezeli M; Végvári A; Ottervald J; Olsson T; Laurell T; Marko-Varga G J Proteomics; 2011 Dec; 75(1):211-20. PubMed ID: 21703369 [TBL] [Abstract][Full Text] [Related]
15. Ultra-centrifuge studies of lipoproteins in multiple sclerosis. AIRD RB; GOFMAN JW; JONES HB; CAMPBELL B; GAROUTTE B Neurology; 1953 Jan; 3(1):22-34. PubMed ID: 13013495 [No Abstract] [Full Text] [Related]
16. Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis. Moreau T; Coles A; Wing M; Isaacs J; Hale G; Waldmann H; Compston A Brain; 1996 Feb; 119 ( Pt 1)():225-37. PubMed ID: 8624684 [TBL] [Abstract][Full Text] [Related]